# Ketamine for Opioid Use Disorder

> **NCT06943859** · PHASE2 · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 50 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Treatment with Ketamine
- **DRUG:** Treatment with Very Low Dose Ketamine

## Key facts

- **NCT ID:** NCT06943859
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2028-08-31
- **Final completion:** 2029-08-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06943859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06943859, "Ketamine for Opioid Use Disorder". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06943859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*